You are here
ASCEMBL
Recruitment period:
10 April 2017Trial period:
15 January 2025For newly diagnosed patients:
noCML: Asciminib shows efficacy and safety in phase 3 ASCEMBL trial
Publish date: January 13, 2021
- Google Plus One
- Share on Facebook
- Log in or register to post comments
- Email this page